Tim M. Mayleben
Overview
Tim M. Mayleben received an average of $850K in total compensation, including $158K in salary, at Landos Biopharma between 2021 and 2022. Tim Mayleben also received an average of $5M at Esperion Therapeutics from 2013 to 2021 and an average of $2M at Vericel between 2011 and 2012.
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Landos BiopharmaFormer President and Chief Executive Officer; Director
Landos BiopharmaPresident, Chief Executive Officer and Director
Esperion TherapeuticsFormer Chief Executive Officer
Esperion TherapeuticsFormer Chief Executive Officer
Esperion TherapeuticsPresident and Chief Executive Officer
Esperion TherapeuticsPresident and Chief Executive Officer
Esperion TherapeuticsPresident and Chief Executive Officer
Esperion TherapeuticsPresident and Chief Executive Officer
Esperion TherapeuticsPresident and Chief Executive Officer
Esperion TherapeuticsPresident and Chief Executive Officer
Source: SEC filings on April 19, 2023, April 28, 2022, April 14, 2022, April 16, 2020, April 18, 2019, April 13, 2018, March 6, 2017, April 28, 2016, and October 21, 2014.
Related executives
We found 27 more executives who work or worked at Landos Biopharma, Esperion Therapeutics, andVericel.
Sheldon Koenig
Esperion Therapeutics
Chief Executive Officer
JoAnne Foody
Esperion Therapeutics
Chief Medical Officer
Eric Warren
Esperion Therapeutics
Chief Commercial Officer
Gregory Oakes
Landos Biopharma
Chief Executive Officer
Benjamin Looker
Esperion Therapeutics
General Counsel
Fabio Cataldi
Landos Biopharma
Chief Medical Officer
Patrick Truesdell
Landos Biopharma
Vice President and Controller
Patricia Bitar
Landos Biopharma
Chief Financial Officer
News
Landos Biopharma CEO Gregory Oakes receives $1.8M in 2022
April 19, 2023
Landos Biopharma Executive Vice President of Operations Jyoti RAC's 2021 pay jumps 195% to $2.8M
April 28, 2022
Esperion Therapeutics CEO Tim Mayleben's 2021 pay rises 19% to $8.2M
April 14, 2022
Esperion Therapeutics CEO Tim Mayleben's 2019 pay falls 89% to $1.1M
April 16, 2020
Esperion Therapeutics CEO Tim Mayleben's 2018 pay jumps 94% to $9.7M
April 18, 2019